Cancer drug resistance induced by EMT: novel therapeutic strategies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer drug resistance induced by EMT: novel therapeutic strategies
Authors
Keywords
-
Journal
ARCHIVES OF TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-18
DOI
10.1007/s00204-021-03063-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer
- (2020) Xin Tong et al. ONCOGENE
- Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer
- (2020) Chao-Yang Lai et al. Cancers
- The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment
- (2020) Casimiro Gerarduzzi et al. CANCER RESEARCH
- Twist1 induces chromosomal instability (CIN) in colorectal cancer cells
- (2020) Maithilee Khot et al. HUMAN MOLECULAR GENETICS
- Guidelines and definitions for research on epithelial–mesenchymal transition
- (2020) Jing Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
- (2020) Prathibha Kirave et al. Oncotarget
- Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression
- (2020) Olaia Martinez-Iglesias et al. Cancers
- Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
- (2020) Sylvie Brassart-Pasco et al. Frontiers in Oncology
- Permissive State of EMT: The Role of Immune Cell Compartment
- (2020) Vita Fedele et al. Frontiers in Oncology
- Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity Correlations
- (2020) Monica M. Arroyo et al. Biomolecules
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Targeting Cancer Cell Dormancy
- (2019) Ariadna Recasens et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
- (2019) Ningning Li et al. Oncogenesis
- Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
- (2019) Tong Liu et al. Molecular Cancer
- Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential
- (2019) Dongsong Nie et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis
- (2019) Ya‐Long Feng et al. MEDICINAL RESEARCH REVIEWS
- Therapy resistance mediated by exosomes
- (2019) Teresa Bernadette Steinbichler et al. Molecular Cancer
- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
- (2019) Suriyamurthy et al. Cancers
- MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells
- (2019) Mingqi Wang et al. GENE
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
- (2019) Sana Raoof et al. ONCOGENE
- TGFβ-induced cytoskeletal remodeling mediates elevation of cell stiffness and invasiveness in NSCLC
- (2019) E. Gladilin et al. Scientific Reports
- Pharmacogenomics in Practice
- (2019) Liewei Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Pharmacogenomics
- (2019) Dan M Roden et al. LANCET
- Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
- (2019) Xiao-Guang Yang et al. Frontiers in Oncology
- Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities
- (2019) Meghan J. Chenoweth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Extracellular Matrix Alterations in Metastatic Processes
- (2019) Paolillo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells
- (2019) Li Jing et al. Scientific Reports
- Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling
- (2018) Yanmei Yi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα
- (2018) Higinio Dopeso et al. CANCER RESEARCH
- Recovering Gene Interactions from Single-Cell Data Using Data Diffusion
- (2018) David van Dijk et al. CELL
- E3 ubiquitin ligase Hakai regulates cell growth and invasion, and increases the chemosensitivity to cisplatin in non‑small‑cell lung cancer cells
- (2018) Zi Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
- (2018) Hsi-Wen Yeh et al. NATURE CELL BIOLOGY
- Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
- (2018) Jinnan Yue et al. ONCOGENE
- CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway
- (2018) Linlin Wang et al. ONCOLOGY REPORTS
- Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
- (2018) Joel P. Joseph et al. ORAL ONCOLOGY
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
- (2018) Tian Fang et al. Nature Communications
- Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer
- (2018) Virginia Murillo-Garzón et al. Nature Communications
- Hakai overexpression effectively induces tumour progression and metastasis in vivo
- (2018) Raquel Castosa et al. Scientific Reports
- Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Scientific Reports
- The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation
- (2018) Stéphanie Duhamel et al. Cell Reports
- Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer
- (2018) Yuichiro Okumura et al. ANNALS OF SURGICAL ONCOLOGY
- LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma
- (2018) Peng-Fei Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma
- (2018) Long Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- A SIRT1-centered circuitry regulates breast cancer stemness and metastasis
- (2018) Lei Shi et al. ONCOGENE
- Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
- (2018) Chien-Hui Weng et al. ONCOGENE
- Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
- (2018) Zachary A. Yochum et al. ONCOGENE
- Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
- (2018) Mohit Kumar Jolly et al. PHARMACOLOGY & THERAPEUTICS
- Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
- (2018) Jonathan T. Lei et al. Cell Reports
- The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
- (2018) Elizabeth Varghese et al. Cancers
- FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells
- (2018) Yuwen He et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TGFβ-Activated USP27X Deubiquitinase Regulates Cell Migration and Chemoresistance via Stabilization of Snail1
- (2018) Guillem Lambies et al. CANCER RESEARCH
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p
- (2018) Mei Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Transforming growth factor‐β signaling: Tumorigenesis and targeting for cancer therapy
- (2018) Amirhossein Ahmadi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer
- (2018) Soon-Ki Hong et al. Molecular Cancer
- Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
- (2018) Kei Namba et al. MOLECULAR CANCER RESEARCH
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
- (2018) Xin Wu et al. Cell Death & Disease
- Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability
- (2018) Toni Celià-Terrassa et al. Nature Communications
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells
- (2017) Emilia Wiechec et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling
- (2017) Ying Xiong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
- (2017) Jacob M. Smigiel et al. MOLECULAR CANCER RESEARCH
- A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer
- (2017) Momeneh Foroutan et al. MOLECULAR CANCER RESEARCH
- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- New insights into the role of EMT in tumor immune escape
- (2017) Stéphane Terry et al. Molecular Oncology
- Upholding a role for EMT in breast cancer metastasis
- (2017) Xin Ye et al. NATURE
- Upholding a role for EMT in pancreatic cancer metastasis
- (2017) Nicole M. Aiello et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
- (2017) Shihua Chu et al. ONCOLOGY REPORTS
- Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
- (2017) Brian Bierie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
- (2017) Charli Dominguez et al. SEMINARS IN CANCER BIOLOGY
- Transforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition
- (2017) Liang Mao et al. Oncology Letters
- A step-by-step microRNA guide to cancer development and metastasis
- (2017) Georgios S. Markopoulos et al. CELLULAR ONCOLOGY
- ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis
- (2017) Sivan Izraely et al. Oncotarget
- Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors
- (2017) Nancy K. Gillis et al. Oncotarget
- Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma
- (2017) Xiao-Long Li et al. Scientific Reports
- Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition
- (2017) Wenzhe Song et al. Frontiers in Immunology
- PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?
- (2017) Cristina Raimondi et al. OncoImmunology
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells
- (2017) An-Fu Lee et al. PLoS One
- miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
- (2017) Hidekazu Hiramoto et al. Scientific Reports
- Cancer Stem Cells: Basic Concepts and Therapeutic Implications
- (2016) Dany Nassar et al. Annual Review of Pathology-Mechanisms of Disease
- The relationship between platinum drug resistance and epithelial–mesenchymal transition
- (2016) Anamaria Brozovic ARCHIVES OF TOXICOLOGY
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
- (2016) Y. Lou et al. CLINICAL CANCER RESEARCH
- The pharmacogenomics of drug resistance to protein kinase inhibitors
- (2016) Nancy K. Gillis et al. DRUG RESISTANCE UPDATES
- The bad seed: Cancer stem cells in tumor development and resistance
- (2016) Elle Koren et al. DRUG RESISTANCE UPDATES
- Immunological Consequences of Epithelial–Mesenchymal Transition in Tumor Progression
- (2016) Peter J. Chockley et al. JOURNAL OF IMMUNOLOGY
- IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
- (2016) Yasushi Shintani et al. Journal of Thoracic Oncology
- Targeting TYRO3 inhibits epithelial–mesenchymal transition and increases drug sensitivity in colon cancer
- (2016) C-W Chien et al. ONCOGENE
- F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check
- (2016) Víctor M. Díaz et al. SEMINARS IN CANCER BIOLOGY
- Signaling Receptors for TGF-β Family Members
- (2016) Carl-Henrik Heldin et al. Cold Spring Harbor Perspectives in Biology
- A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
- (2016) Ruby Yun-Ju Huang et al. Cell Death & Disease
- MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells
- (2016) Jingyi Yu et al. Nature Communications
- PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
- (2016) Chan-Young Ock et al. Oncotarget
- miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET
- (2016) Qing-yong Chen et al. Oncotarget
- EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells
- (2016) Jinkyoung Kim et al. Oncotarget
- Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
- (2016) Sabina Sangaletti et al. Cell Reports
- Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration
- (2016) Christine Mayer et al. Journal of Cancer
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- (2016) Claudia Cantoni et al. Journal of Immunology Research
- Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma
- (2016) Adrian Biddle et al. EBioMedicine
- MicroRNA Regulation of Epithelial to Mesenchymal Transition
- (2016) Mohammed Abba et al. Journal of Clinical Medicine
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
- (2016) Jingyu Zhang et al. Journal of Clinical Medicine
- Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124
- (2016) Peixin Dong et al. Scientific Reports
- Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
- (2016) Ryuji Matsumoto et al. Scientific Reports
- Multidrug Resistance Proteins (MRPs) and Cancer Therapy
- (2015) Yun-Kai Zhang et al. AAPS Journal
- Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells
- (2015) M Ricciardi et al. BRITISH JOURNAL OF CANCER
- Clinical implications of epithelial cell plasticity in cancer progression
- (2015) Luis A. Aparicio et al. CANCER LETTERS
- Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer
- (2015) S. K. Martin et al. CANCER RESEARCH
- A Systematic Approach to Defining the microRNA Landscape in Metastasis
- (2015) G. Mudduluru et al. CANCER RESEARCH
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
- (2015) M. P. Mak et al. CLINICAL CANCER RESEARCH
- IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization
- (2015) Aude I. Ségaliny et al. CYTOKINE
- HIF-1 at the crossroads of hypoxia, inflammation, and cancer
- (2015) Kuppusamy Balamurugan INTERNATIONAL JOURNAL OF CANCER
- Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer
- (2015) MASAYOSHI TOGE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
- (2015) Anamaria Brozovic et al. Molecular Oncology
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
- (2015) Alexandre Calon et al. NATURE GENETICS
- CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer
- (2015) Y-C Wu et al. ONCOGENE
- Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells
- (2015) ICHIRO OTA et al. ONCOLOGY REPORTS
- Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression
- (2015) Xin Ye et al. TRENDS IN CELL BIOLOGY
- Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT
- (2015) Eugenio Zoni et al. Journal of Oncology
- Breast cancer stem cells, EMT and therapeutic targets
- (2014) Srishti Kotiyal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression
- (2014) Vivek Kumar Mishra et al. CELL AND TISSUE RESEARCH
- Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells
- (2014) Rui Wang et al. CURRENT CANCER DRUG TARGETS
- Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
- (2014) T. Z. Tan et al. EMBO Molecular Medicine
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- INK4locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform
- (2014) Xiao Tian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Epithelial-to-Mesenchymal Transition Activates PERK-eIF2 and Sensitizes Cells to Endoplasmic Reticulum Stress
- (2014) Y.-x. Feng et al. Cancer Discovery
- Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
- (2014) Stephan Lindsey et al. Frontiers in Oncology
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
- (2013) Y Yu et al. BRITISH JOURNAL OF CANCER
- The role played by the microenvironment in site-specific metastasis
- (2013) Anat Klein-Goldberg et al. CANCER LETTERS
- Identification of Two Distinct Carcinoma-Associated Fibroblast Subtypes with Differential Tumor-Promoting Abilities in Oral Squamous Cell Carcinoma
- (2013) Daniela Elena Costea et al. CANCER RESEARCH
- Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition
- (2013) Luis A. Aparicio et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6
- (2013) Abulimiti Abulaiti et al. LUNG CANCER
- MiR-134/487b/655 Cluster Regulates TGF- -Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
- (2013) K. Kitamura et al. MOLECULAR CANCER THERAPEUTICS
- High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat
- (2013) Xiao Tian et al. NATURE
- Tumor and its microenvironment: A synergistic interplay
- (2013) Veronica Catalano et al. SEMINARS IN CANCER BIOLOGY
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- MicroRNA control of epithelial–mesenchymal transition and metastasis
- (2012) Jinsong Zhang et al. CANCER AND METASTASIS REVIEWS
- Biological influence of Hakai in cancer: a 10-year review
- (2012) Luis A. Aparicio et al. CANCER AND METASTASIS REVIEWS
- The tumor microenvironment is a dominant force in multidrug resistance
- (2012) Ana Luísa Correia et al. DRUG RESISTANCE UPDATES
- Tumor microenvironment regulates epithelial–mesenchymal transitions in metastasis
- (2012) Dingcheng Gao et al. Expert Review of Anticancer Therapy
- LOXL2 in epithelial cell plasticity and tumor progression
- (2012) Amparo Cano et al. Future Oncology
- Pharmacogenomics in clinical practice and drug development
- (2012) Andrew R Harper et al. NATURE BIOTECHNOLOGY
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
- (2011) R. O. Hynes et al. Cold Spring Harbor Perspectives in Biology
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
- (2011) Benjamin Toh et al. PLOS BIOLOGY
- Regulation of mRNA Translation and Stability by microRNAs
- (2010) Marc Robert Fabian et al. Annual Review of Biochemistry
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms
- (2010) Bryan L. Copple LIVER INTERNATIONAL
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Pharmacogenetics and pharmacogenomics of anticancer agents
- (2009) R. S. Huang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
- (2009) Chie Kudo-Saito et al. CANCER CELL
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Novel Roles of Hakai in Cell Proliferation and Oncogenesis
- (2009) Angélica Figueroa et al. MOLECULAR BIOLOGY OF THE CELL
- A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition
- (2009) Theresa Vincent et al. NATURE CELL BIOLOGY
- SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
- (2009) A. E. Sayan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Yin-Yang Activities and Vicious Cycles in the Tumor Microenvironment
- (2008) I. P. Witz CANCER RESEARCH
- Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
- (2008) Michèle Sabbah et al. DRUG RESISTANCE UPDATES
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Cadherin switching
- (2008) M. J. Wheelock et al. JOURNAL OF CELL SCIENCE
- Direct regulation of TWIST by HIF-1α promotes metastasis
- (2008) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search